We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[Treatment of humeral shaft fractures with Russell-Taylor interlocking intramedullar nail].
Hunan Yi Ke da Xue Xue Bao = Hunan Yike Daxue Xuebao = Bulletin of Hunan Medical University 2003 April
OBJECTIVE: To evaluate the clinical effects of Russell-Taylor interlocking intramedullar nail (RT nail) on humeral shaft fractures.
METHODS: Twenty six patients with humeral shaft fractures were treated with RT nail, of whom 19 cases were treated with antegrade RT nail and 7 cases with retrograde RT nail.
RESULTS: With an average of 16 months (range 6-24 months) of follow-up, all cases acquired bony union with mean union time 4.7 months (range 3-8 months). The recovery of shoulder function was excellent in 18 cases, good in 5 cases, and fair in 3 cases. The recovery of elbow function was excellent in 23 cases and good in 3 cases. One case had shoulder impingement caused by proximal locking screw. All cases had no infection, iatrogenic fracture, and peripheral nerve injury.
CONCLUSION: RT nail is an effective method for the treatment of humeral shaft fractures.
METHODS: Twenty six patients with humeral shaft fractures were treated with RT nail, of whom 19 cases were treated with antegrade RT nail and 7 cases with retrograde RT nail.
RESULTS: With an average of 16 months (range 6-24 months) of follow-up, all cases acquired bony union with mean union time 4.7 months (range 3-8 months). The recovery of shoulder function was excellent in 18 cases, good in 5 cases, and fair in 3 cases. The recovery of elbow function was excellent in 23 cases and good in 3 cases. One case had shoulder impingement caused by proximal locking screw. All cases had no infection, iatrogenic fracture, and peripheral nerve injury.
CONCLUSION: RT nail is an effective method for the treatment of humeral shaft fractures.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app